Altium Capital Management »

Chavant Capital Acquisitn shares owned by Altium Capital Management

Quarter-by-quarter ownership of Chavant Capital Acquisitn shares owned by Altium Capital Management from 13F filings

Historical chart of Altium Capital Management investment in Chavant Capital Acquisitn

Tip: Access up to 7 years of quarterly data

All positions including Chavant Capital Acquisitn held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Chavant Capital Acquisitn by Altium Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.4k 150k 0.03
2023-06-30 $6.5k 150k 0.04
2023-03-31 $4.7k 150k 0.03
2022-12-31 $22k 150k 0.14
2022-09-30 $7.0k 150k 0.05
2022-06-30 $11k 150k 0.07
2022-03-31 $30k 150k 0.20
2021-12-31 $74k 150k 0.49
2021-09-30 $85k 150k 0.57

More positions owned by Altium Capital Management

Cymabay Therapeutics
Immunovant Put Put Option
ImmunoGen
Astria Therapeutics (ATXS)
Xtant Med Hldgs Com New (XTNT)
Amylyx Pharmaceuticals (AMLX)
Adma Biologics (ADMA)
Alimera Sciences Com New (ALIM)
Structure Therapeutics Sponsored Ads (GPCR)
Crinetics Pharmaceuticals In (CRNX)
Xenon Pharmaceuticals (XENE)
Biohaven (BHVN)
Axsome Therapeutics (AXSM)
Karuna Therapeutics Ord
Moonlake Immunotherapeutics Class A Ord (MLTX)

View all positions for Altium Capital Management

Top funds holding Chavant Capital Acquisitn

Arena Capital Advisors, LLC- CA

View all funds holding Chavant Capital Acquisitn